From Reactive to Roadmap in 6 Weeks.

R&D organizations are under more pressure than ever…to move faster, do more, and get it right the first time. Yet many leadership teams find themselves managing complexity rather than driving progress: launching initiatives without a clear strategic pathway, struggling to align stakeholders, and unsure where to focus to unlock real impact.

The Molecule-to-Market Value Sprint changes that.

What Is the Value Sprint?

The Value Sprint is a focused, 6-week engagement designed to help R&D organizations cut through complexity, identify high-impact opportunities, and build a clear, actionable roadmap — fast.

In six weeks, you get:

  • A Constraint Map — a structured view of where speed, quality, or confidence is breaking down in your selected focus area, and where untapped opportunities exist
  • A Prioritized Initiative Set — a clear, ranked list of initiatives to resolve your key challenge
  • Quantified Value Cases — a measurable business case for each initiative, tied to real operational and financial outcomes
  • An Implementation Plan — a governance-ready 30/60/90-day roadmap with owners, timelines, decision gates, and key interdependencies

Who It's For

The Value Sprint is built for R&D leaders who need answers, not another assessment that gathers dust. It can be scoped to one or more focus areas depending on your priorities. Below are some examples of challenges the Value Sprint can help you tackle:
Innovation & Discovery
  • AI/ML Vendor Rapid Assessment — Overwhelmed by the vendor landscape and need a systematic way to evaluate options?
  • Disease Biology Deep-Dive — Entering a new therapeutic area and need to build expertise quickly?
  • Generative AI Readiness Assessment — Board-level questions about GenAI and need an objective, credible view?
Clinical Development & Operations
  • Protocol Optimization Review — Concerns about trial complexity and feasibility before finalizing a protocol?
  • Enrollment Rescue Diagnostic — Trial underperforming with unclear root causes?
  • Site Activation Accelerator — Persistent start-up delays affecting timelines?
  • Patient Recruitment Strategy Refresh — Campaigns underperforming and diversity goals at risk?
Regulatory Strategy & Post-Market Surveillance
  • Pharmacovigilance (PV) System Health Check — Upcoming inspection with uncertain readiness?
  • Pre-IND Strategy and Package Review — Approaching the FDA and uncertain about positioning?
  • Regulatory Pathway Optimization — Questions about designations, sequencing, and strategic options?
R&D Strategy & Operations
  • Portfolio Prioritization Sprint — Resources spread thin and in need of a data-driven framework?
  • R&D Operating Model Diagnostic — Productivity lagging against benchmarks?
  • Governance Decision Framework Design — Inconsistent stage-gates slowing decisions?
  • Clinical Development Plan Refresh — Outdated CDP ahead of a critical governance review?

How It Works

Every Value Sprint is tailored to the client’s unique needs, but follows a proven structure:

Let’s Talk

If your R&D organization is facing a challenge that demands clarity and momentum, the Value Sprint may be exactly what you need (download a fact sheet).

Complete the form below to request a 30-minute call. We’ll discuss your goals, your most pressing challenges, and whether a Value Sprint is the right fit, with no commitment required.